Get notified when MRK files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsMerck reports Q4 and full-year 2025 earnings results
Filed February 3, 2026 · Period ending February 3, 2026 · ~1 min read
Key Changes
-
high
Merck disclosed fourth quarter and full-year 2025 financial results through a press release and supplemental materials. Actual revenue, earnings per share, and guidance details are contained in the attached exhibits.
Item 2.02 verify on EDGAR → -
medium
Additional financial details provided in supplemental information include segment breakdowns and product-level revenue not included in the main press release.
Exhibit 99.2 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade MRK commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 19, 2026 · How we verify